Clearmind Medicine Inc.
NASDAQ: CMND0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Adi Zuloff-Shani
- Employees
- 4
- Headquarters
- Vancouver, Canada
- IPO year
- 2022
- Market cap
- $2.7M
- Website
- https://www.clearmindmedicine.com
Loading CMND…
Loading profile data…Frequently asked questions about CMND
What does Clearmind Medicine Inc. (CMND) do?
Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (inc...
Where does CMND trade?
Clearmind Medicine Inc. (CMND) trades on the NASDAQ Capital Market.
What sector is CMND in?
Clearmind Medicine Inc. (CMND) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Clearmind Medicine Inc.?
Adi Zuloff-Shani is the chief executive officer of Clearmind Medicine Inc. (CMND).
Where is Clearmind Medicine Inc. headquartered?
Clearmind Medicine Inc. is headquartered in Canada.
Does CMND pay a dividend?
Clearmind Medicine Inc. (CMND) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CMND go public?
Clearmind Medicine Inc. (CMND) completed its initial public offering in 2022.